BioLight to Present its IOPtiMate™ System at the Ophthalmology Innovation Summit @ the American Academy of Ophthalmology 2014
PR Newswire BioLight Life Sciences Investments Ltd
TEL AVIV, Israel, October 13, 2014 /PRNewswire/ --
BioLight Life Sciences Investments Ltd.(BOLT.TA)(BLGTY), a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, announced today that Ronen Castro, CEO of its subsidiary IOPtima Ltd., will present at the OIS@AAO (Ophthalmology Innovation Summit @ the American Academy of Ophthalmology) on Thursday, October 16, 2014, at 10:55 a.m. at the Palmer House Hilton in Chicago, IL.
The IOPtiMate™ system uses CO2 laser technology to perform a unique filtration surgery that treats glaucoma without penetrating the inner part of the eyeball. This innovation reduces post-operative complications and the use of eye drops compared with alternatives.
